Synergistic interaction between pay-it-forward incentives and recreational drug use on hepatitis B virus and hepatitis C virus testing among men who have sex with men in China

Author:

Ai WeiORCID,Xie Yewei,Lu Haidong,Ai Ting,Wu Dan,Zhang Ye,Marley Gifty,Ong Jason,Tucker Joseph DORCID,Tang WeimingORCID

Abstract

ObjectivesPay-it-forward incentives effectively promote hepatitis B virus (HBV) and hepatitis C virus (HCV) testing among men who have sex with men (MSM) by offering free testing and donation opportunities. This study aims to explore the interaction between pay-it-forward incentives and recreational drug use on HBV and HCV testing uptake among Chinese MSM.MethodsWe pooled data from two pay-it-forward studies that aimed to promote dual HBV and HCV testing among MSM in Jiangsu, China. We explored factors associated with hepatitis testing uptake in the two study groups and examined the interaction between pay-it-forward incentives and recreational drug use on hepatitis testing uptake.ResultsOverall, 511 MSM participated in these two studies, with 265 participants in the pay-it-forward incentives group and 246 participants in the standard-of-care group. Among these participants, 59.3% in the pay-it-forward incentive group and 24.8% in the standard-of-care group received dual HBV and HCV testing, respectively. In the pay-it-forward incentives group, participants who used recreational drugs in the past 12 months (adjusted OR (AOR)=1.83, 95% CI 1.09 to 3.06) were more likely to receive dual HBV and HCV testing, compared with those who never used recreational drugs, whereas in the standard-of-care group, those who used recreational drugs were less likely to receive dual HBC and HCV testing (AOR=0.38, 95% CI 0.18 to 0.78). MSM with higher community connectedness (AOR=1.10, 95% CI 1.00 to 1.21) were also more likely to receive hepatitis testing with pay-it-forward incentives. There was a synergistic interaction on both the multiplicative (ratio of ORs=4.83, 95% CI 1.98 to 11.7) and additive scales (the relative excess risk of interaction=2.97, 95% CI 0.56 to 5.38) of pay-it-forward incentives and recreational drug use behaviours on dual HBV and HCV testing uptake among MSM.ConclusionPay-it-forward incentives may be particularly useful in promoting hepatitis testing among MSM who use recreational drugs.

Funder

National Nature Science Foundation of China

National Institute of Health

CRDF Global

Key Technologies Research and Development Program

Publisher

BMJ

Reference30 articles.

1. World Health Organization . Combating hepatitis B and C to reach elimination by 2030: advocacy brief. 2016. Available: https://www.who.int/publications/i/item/combating-hepatitis-b-and-c-to-reach-elimination-by-2030 [Accessed 4 Nov 2023].

2. Global reporting of progress towards elimination of hepatitis B and hepatitis C;Cui;Lancet Gastroenterol Hepatol,2023

3. Shared-care models are highly effective and cost-effective for managing chronic hepatitis B in China: reinterpreting the primary care and specialty divide;Zhang;Lancet Reg Health West Pac,2023

4. Modeling the impacts of prevention and treatment interventions on hepatitis C among people who inject drugs in China;Fang;Infect Dis Ther,2023

5. A randomized controlled trial enhancing viral hepatitis testing in primary care via digital crowdsourced intervention;Wong;NPJ Digit Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3